Two missense mutations in SALL4 in a patient with microphthalmia, coloboma, and optic nerve hypoplasia

ABSTRACT To investigate the genetic etiology of anophthalmia and microphthalmia, we used exome sequencing in a Caucasian female with unilateral microphthalmia and coloboma, bilateral optic nerve hypoplasia, ventricular and atrial septal defects, and growth delays. We found two sequence variants in SALL4 - c.[575C>A], predicting p.(Ala192Glu), that was paternally inherited, and c.[2053G>C], predicting p.(Asp685His), that was maternally inherited. Haploinsufficiency for SALL4 due to nonsense or frameshift mutations has been associated with acro-renal ocular syndrome that is characterized by eye defects including Duane anomaly and coloboma, in addition to radial ray malformations and renal abnormalities. Our report is the first description of structural eye defects associated with two missense variants in SALL4 inherited in trans; the absence of reported findings in both parents suggests that both sequence variants are hypomorphic mutations and that both are needed for the ocular phenotype. SALL4 is expressed in the developing lens and regulates BMP4, leading us to speculate that altered BMP4 expression was responsible for the eye defects, but we could not demonstrate altered BMP4 expression in vitro after using small interfering RNAs (siRNAs) to reduce SALL4 expression. We conclude that SALL4 hypomorphic variants may influence eye development.

[1]  P. Kwok,et al.  Exome sequencing in 32 patients with anophthalmia/microphthalmia and developmental eye defects , 2015, Clinical genetics.

[2]  J. Kohlhase.  SALL4-Related Disorders , 2015 .

[3]  L. Reis,et al.  Whole exome analysis identifies dominant COL4A1 mutations in patients with complex ocular phenotypes involving microphthalmia , 2014, Clinical genetics.

[4]  R. Harland,et al.  Spalt-like 4 promotes posterior neural fates via repression of pou5f3 family members in Xenopus , 2014, Development.

[5]  M. Bitner-Glindzicz,et al.  Mutation of SALL2 causes recessive ocular coloboma in humans and mice , 2014, Human molecular genetics.

[6]  C. Simons,et al.  Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1 , 2013, European Journal of Human Genetics.

[7]  Arthur Wuster,et al.  DeNovoGear: de novo indel and point mutation discovery and phasing , 2013, Nature Methods.

[8]  P. Kwok,et al.  Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1. , 2013, Human molecular genetics.

[9]  M. Shahhoseini,et al.  Comparative SRY incorporation on the regulatory regions of pluripotency/differentiation genes in human embryonic carcinoma cells after retinoic acid induction , 2013, Molecular and Cellular Biochemistry.

[10]  Murat Sincan,et al.  Detecting false‐positive signals in exome sequencing , 2012, Human mutation.

[11]  S. Ware,et al.  Implications for genotype–phenotype predictions in Townes–Brocks syndrome: Case report of a novel SALL1 deletion and review of the literature , 2012, American journal of medical genetics. Part A.

[12]  A. Slavotinek.  Eye development genes and known syndromes. , 2011, Molecular genetics and metabolism.

[13]  D. Rakheja,et al.  Immunoexpression of SALL4 in Wilms Tumors and Developing Kidney , 2011, Pathology & Oncology Research.

[14]  F. Lopitz-Otsoa,et al.  Sumoylation Modulates the Activity of Spalt-like Proteins during Wing Development in Drosophila* , 2010, The Journal of Biological Chemistry.

[15]  L. Biesecker,et al.  Association of a de novo 16q copy number variant with a phenotype that overlaps with Lenz microphthalmia and Townes-Brocks syndromes , 2009, BMC Medical Genetics.

[16]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[17]  Li Chai,et al.  Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[18]  M. Bamshad,et al.  Multigene deletions on chromosome 20q13.13‐q13.2 including SALL4 result in an expanded phenotype of Okihiro syndrome plus developmental delay , 2007, Human mutation.

[19]  R. Depping,et al.  Synergistic cooperation of Sall4 and Cyclin D1 in transcriptional repression. , 2007, Biochemical and biophysical research communications.

[20]  Harini Chakravarthy,et al.  Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes† , 2007, Nucleic acids research.

[21]  Christian Wilhelm,et al.  SALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway. , 2006, Biochemical and biophysical research communications.

[22]  X. Chen,et al.  Sall4 Interacts with Nanog and Co-occupies Nanog Genomic Sites in Embryonic Stem Cells* , 2006, Journal of Biological Chemistry.

[23]  H. Aburatani,et al.  The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development , 2006, Development.

[24]  A. Amoroso,et al.  A SALL4 zinc finger missense mutation predicted to result in increased DNA binding affinity is associated with cranial midline defects and mild features of Okihiro syndrome , 2006, Human Genetics.

[25]  A. Green,et al.  SALL1 mutation analysis in Townes‐Brocks syndrome: twelve novel mutations and expansion of the phenotype , 2005, Human mutation.

[26]  D. Chitayat,et al.  SALL4 mutations in Okihiro syndrome (Duane‐radial ray syndrome), acro‐renal‐ocular syndrome, and related disorders , 2005, Human mutation.

[27]  W. Reardon,et al.  SALL4 deletions are a common cause of Okihiro and acro-renal-ocular syndromes and confirm haploinsufficiency as the pathogenic mechanism , 2004, Journal of Medical Genetics.

[28]  R. Hennekam,et al.  Novel mutations in the gene SALL4 provide further evidence for acro-renal-ocular and Okihiro syndromes being allelic entities, and extend the phenotypic spectrum , 2004, Journal of Medical Genetics.

[29]  W. Reardon,et al.  Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy , 2003, Journal of medical genetics.

[30]  Stanley C. Smith,et al.  Transcriptional Profiling of Neuronal Differentiation by Human Embryonal Carcinoma Stem Cells In Vitro , 2003, Stem cells.

[31]  W. Reardon,et al.  Okihiro syndrome is caused by SALL4 mutations. , 2002, Human molecular genetics.

[32]  C. St. Hilaire,et al.  Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. , 2002, American journal of human genetics.

[33]  R. Hennekam,et al.  Further delineation of the acro-renal-ocular syndrome. , 1996, American journal of medical genetics.

[34]  Andrew ONI Wilkie,et al.  Syndrome of themonth , 1988 .

[35]  F. Halal,et al.  Acro-renal-ocular syndrome: autosomal dominant thumb hypoplasia, renal ectopia, and eye defect. , 1984, American journal of medical genetics.

[36]  J. Peterson,et al.  Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner. , 2015, Experimental hematology.

[37]  Sumiko Watanabe,et al.  Sox2 plays a role in the induction of amacrine and Müller glial cells in mouse retinal progenitor cells. , 2009, Investigative ophthalmology & visual science.

[38]  Claude-Alain H. Roten,et al.  Theoretical and practical advances in genome halving , 2004 .

[39]  J. Kohlhase,et al.  Animal Cytogenetics and Comparative Mapping , 2003 .

[40]  W. Engel,et al.  Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome , 1998, Nature Genetics.